Novel pharmacology of putative cannabinoid targets and their ligands
The novel compound VSN16R was characterised and its functional effect in the central nervous system and periphery was investigated. VSN16R behaved as an agonist in the mouse isolated vas deferens assay. The functional effect of VSN16R appeared to involve GPR55 and GPR18 activation. The possibility...
Main Author: | |
---|---|
Published: |
University of Aberdeen
2010
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.531908 |